Key market opportunities for mesenchymal stem cells include advancements in regenerative medicine, growing investments in R&D ...

A First-in-Class Regenerative Medical Product for Meniscal Injury -- FUJIFILM Corporation (President and CEO, Representative ...

Biotech company CellResearchCorp pivoted to cosmeceutical products due to the pandemic. Read more at straitstimes.com. Read ...

Aerobic glycolysis dominates lesion bioenergetics, with lactate promoting histone lactylation, M2 macrophage polarization, CD8⁺ T-cell exhaustion, EMT, and fibrosis that reinforce immune-protected ...

Oral presentation at ISCT 2026 included larger 52-week follow-up cohort, with 52% of evaluable patients achieving at least 50% improvement in ...

KALA BIO on May 7, 2026 filed a Certificate of Amendment in Delaware to implement a 1-for-50 reverse stock split of its common stock, effective May 8, 2026, following shareholder approval granted at a ...

Gallant, an animal health biotechnology company pioneering off-the-shelf mesenchymal stromal cell (MSC) therapies for pets, today announced that its canine osteoarthritis (OA) MSC therapy program has ...

Shapes of beaks and snouts come in an extraordinary range of forms, reflecting adaptations to different lifestyles and ...

Oral presentation at ISCT 2026 included larger 52-week follow-up cohort, with 52% of evaluable patients achieving at least 50% improvement in both VAS pain and ODI function measures and no dose-limiti ...

R3 Stem Cell's trademark for "Regenerative Trifecta" formalizes the brand identity of a clinical protocol used across ...